enzalutamide
Sign in to saveAlso known as MDV-3100, MDV3100, MDV 3100
Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer. It is indicated for use in conjunction with castration in the treatment of metastatic castration-resistant prostate cancer (mCRPC), nonmetastatic castration-resistant prostate cancer, and metastatic castration-sensitive prostate cancer (mCSPC). It is taken by mouth.
Key facts
- Drug.image
- Enzalutamide-01.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250
- Drug.width2
- 250
- Drug.tradename
- Xtandi
- Drug.MedlinePlus
- a612033
- Drug.DailyMedID
- Enzalutamide
- Drug.pregnancy_AU
- X
- Drug.routes_of_administration
- By mouth
- Drug.class
- Nonsteroidal antiandrogen
- Drug.ATC_prefix
- L02
- Drug.ATC_suffix
- BB04
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
- Drug.legal_US
- Rx-only
- Drug.legal_EU
- Rx-only
- Drug.bioavailability
- Rats: 89.7%Humans: unknown (but at least 84.6% based on recovery from excretion)
- Drug.protein_bound
- Enzalutamide: 97–98% (primarily to albumin): 95%
via Wikipedia infobox
~16 min read
Encyclopedic overview
27 sectionsContents
- Medical uses
- Prostate cancer
- Other uses
- Available forms
- Contraindications
- Side effects
- Central adverse effects
- Rare adverse reactions
- Overdose
- Interactions
- Pharmacology
- Pharmacodynamics
- Changes in hormone levels
- Comparison with other antiandrogens
- Resistance mechanisms in prostate cancer
- Cytochrome P450 modulation
- Pharmacokinetics
- Chemistry
- History
- Society and culture
- Legal status
- Economics
- Research
- Breast cancer
- Hirsutism
- See also
- References
{{Infobox drug | image = Enzalutamide-01.svg | image_class = skin-invert-image | width = 250 | alt = | width2 = 250 | alt2 =
| pronounce = | tradename = Xtandi | Drugs.com = | MedlinePlus = a612033 | DailyMedID = Enzalutamide | pregnancy_AU = X | pregnancy_AU_comment = | routes_of_administration = By mouth | class = Nonsteroidal antiandrogen | ATC_prefix = L02 | ATC_suffix = BB04 | ATC_supplemental =
Excerpted from Wikipedia’s “enzalutamide” article, available under the CC BY-SA 4.0 licence.